Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant

Kidney Int. 2022 Aug;102(2):442-444. doi: 10.1016/j.kint.2022.05.008. Epub 2022 May 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • HIV Infections*
  • Humans
  • Pre-Exposure Prophylaxis*

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral